145 related articles for article (PubMed ID: 3886724)
41. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria.
Kosnik M; Subic T
Respir Med; 2011 Oct; 105 Suppl 1():S84-8. PubMed ID: 22015095
[TBL] [Abstract][Full Text] [Related]
42. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
Najib U; Bajwa ZH; Ostro MG; Sheikh J
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):496-501. PubMed ID: 20084843
[TBL] [Abstract][Full Text] [Related]
43. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria.
Breneman DL
Ann Pharmacother; 1996 Oct; 30(10):1075-9. PubMed ID: 8893110
[TBL] [Abstract][Full Text] [Related]
44. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
Feighner J; Hendrickson G; Miller L; Stern W
J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
[TBL] [Abstract][Full Text] [Related]
45. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
46. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
Feighner JP; Cohn JB
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
48. Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.
Ferguson J; MacDonald KJ; Kenicer KJ
Br J Clin Pharmacol; 1985 Dec; 20(6):639-41. PubMed ID: 3937549
[TBL] [Abstract][Full Text] [Related]
49. Doxepin or diazepam for anxious and anxious-depressed outpatients?
Haskell DS; Gambill JD; Gardos G; McNair DM; Fisher S
J Clin Psychiatry; 1978 Feb; 39(2):135-9. PubMed ID: 344303
[TBL] [Abstract][Full Text] [Related]
50. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
Monroe EW
Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
[TBL] [Abstract][Full Text] [Related]
51. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
53. The essential role of anti-thyroid antibodies in chronic idiopathic urticaria.
Wan KS; Wu CS
Endocr Res; 2013; 38(2):85-8. PubMed ID: 22889002
[TBL] [Abstract][Full Text] [Related]
54. Treatment options for the relief of chronic idiopathic urticaria symptoms.
Fromer L
South Med J; 2008 Feb; 101(2):186-92. PubMed ID: 18364622
[TBL] [Abstract][Full Text] [Related]
55. Association between chronic urticaria and thyroid autoimmunity: a prospective study involving 99 patients.
Verneuil L; Leconte C; Ballet JJ; Coffin C; Laroche D; Izard JP; Reznik Y; Leroy D
Dermatology; 2004; 208(2):98-103. PubMed ID: 15056996
[TBL] [Abstract][Full Text] [Related]
56. Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies.
Asero R; Lorini M; Tedeschi A
J Allergy Clin Immunol; 2003 May; 111(5):1129-30. PubMed ID: 12743581
[No Abstract] [Full Text] [Related]
57. Low-dose doxepin for treatment of pruritus in patients on hemodialysis.
Pour-Reza-Gholi F; Nasrollahi A; Firouzan A; Nasli Esfahani E; Farrokhi F
Iran J Kidney Dis; 2007 Jul; 1(1):34-7. PubMed ID: 19357442
[TBL] [Abstract][Full Text] [Related]
58. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Marsland AM; Soundararajan S; Joseph K; Kaplan AP
Clin Exp Allergy; 2005 May; 35(5):554-9. PubMed ID: 15898974
[TBL] [Abstract][Full Text] [Related]
59. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Jones DH; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
[TBL] [Abstract][Full Text] [Related]
60. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients.
Dover JS; Black AK; Ward AM; Greaves MW
J Am Acad Dermatol; 1988 Jun; 18(6):1289-98. PubMed ID: 3385044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
